About Iovance (IOVA)
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own imm... Read more
- USD1.81
- USD2.05
- USD1.81
- USD12.51
- -33.90%
- 213M
- 20.62M
- 14.09M
- 584M
- 1.64
- -74.80%
Stock News
5 hours ago
Default Risk Rises For Most U.S. Sectors At May-End As Market Volatility Eases
SeekingAlpha
6 hours ago
Dividend Champion, Contender, And Challenger Highlights: Week Of June 8
SeekingAlpha
6 hours ago
Harder Times For The Young And Educated
SeekingAlpha
7 hours ago
Nvidia Back In Focus And AI Infrastructure Acceleration
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
